Candida albicans shunt infection

Pediatr Neurosci. 1989;15(3):125-30.


Seven cases of successfully treated Candida albicans cerebrospinal fluid shunt infections are reported. Treatment consisted of shunt removal and intravenous Amphotericin B in all cases and intraventricular Amphotericin B in 4 cases. Serious underlying medical illness, recent antibiotic therapy, indwelling intravascular and/or Foley catheters, coincident candidiasis and low birth weight prematurity are major risk factors for candida shunt infection. Candida shunt infection appears to occur by either contamination at the time of shunt placement or by hematogenous dissemination.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adolescent
  • Aged
  • Amphotericin B / therapeutic use
  • Anti-Bacterial Agents / adverse effects
  • Candidiasis / drug therapy
  • Candidiasis / etiology*
  • Catheters, Indwelling
  • Cerebrospinal Fluid Shunts / adverse effects*
  • Equipment Contamination
  • Female
  • Humans
  • Infant, Newborn
  • Infant, Premature
  • Male
  • Opportunistic Infections / etiology*
  • Risk Factors
  • Sepsis / complications
  • Sepsis / drug therapy
  • Surgical Wound Infection / drug therapy
  • Surgical Wound Infection / etiology


  • Anti-Bacterial Agents
  • Amphotericin B